LGD-4033 in Thailand: Selective Androgen & Muscle Support Therapy
LGD-4033 (Ligandrol) is a selective androgen receptor modulator investigated for its ability to support lean muscle development, strength enhancement, and body composition improvement with tissue selectivity. In physician-supervised protocols, it is used for muscle preservation, athletic performance support, and body composition optimization.
Doctor-prescribed LGD-4033 in Thailand is available at Peptides Thailand under physician supervision, with clinical-grade, COA-verified oral capsules. It is prescribed in structured cycling protocols with physician monitoring of hormonal status, most frequently for patients with specific lean muscle and body composition goals.
How LGD-4033 Works
LGD-4033 operates through sophisticated pathways to enhance muscle development. Its primary mechanism involves selectively binding to androgen receptors in muscle and bone tissue, promoting anabolic activity while minimizing effects on other tissues. The compound also demonstrates significant effects on protein synthesis and nitrogen retention.
Medical Review Status
Last reviewed: June 2026 | Next review: December 2026
Written by Dr. Michael Ackland · Medically reviewed by Dr. Ploy Pitayanon, MD, licensed by the Medical Council of Thailand
At a Glance
Peptide
LGD-4033
Category
Oral Peptide
Dosage
500mcg
Frequency
1 capsule daily in a 30-day cycle (then off)
Administration
Oral capsules
Potential Benefits
- · Promotes lean muscle growth
- · Enhances strength gains
- · Supports fat loss
Quality Matters
Why we use Clinical-Grade only
Certificate of Analysis
Every peptide we dispense comes with a third-party COA confirming purity and potency, never grey-market sourced.
Compounded in Thailand
Manufactured in Thai FDA-licensed compounding laboratories operating under GMP standards.
Physician-prescribed only
No dispensing without a prescription. Every protocol begins with a licensed physician consultation and clinical assessment.
Medical Disclaimer
The information on this page is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Any therapies, consultations, or prescriptions are provided only following assessment by a licensed physician and where clinically appropriate. Individual results may vary and no specific outcomes are guaranteed. Certain compounds discussed may not be approved medicines registered with the Thai FDA for specific therapeutic indications. Nothing here should be interpreted as a recommendation to self diagnose, self treat, or replace consultation with a qualified healthcare professional.
Doctor's Note
Dr. Ploy Pitayanon, MD, Medical Lead
LGD-4033 requires careful medical supervision and individualized dosing. Our clinics in Chiang Mai and Phuket provide comprehensive assessment, monitoring, and ongoing support to ensure safe and effective treatment outcomes.
Potential Benefits
Promotes lean muscle growth
Enhances strength gains
Supports fat loss
Improves recovery
Maintains muscle mass
Enhances bone density
Supports athletic performance
Improves endurance
Accelerates recovery
Optimizes body composition
Speak with a physician
Interested in LGD-4033?
All protocols require a physician assessment before any prescription is issued. Book a free video consultation with an MCT-licensed doctor.
Treatment Protocol
Dosage
500mcg
Frequency
1 capsule daily in a 30-day cycle (then off)
Duration
30 days on, 30 days off
Administration
Oral capsules
Safety guide
LGD-4033 Side Effects & Safety
Frequency, contraindications, and who is a good candidate
Recent LGD-4033 Research
LGD-4033 and a Case of Drug-Induced Liver Injury: Clinical Implications of Off-Label SARM Use
Documented a case of drug-induced liver injury associated with LGD-4033 use, highlighting the importance of medical supervision and clinical monitoring when considering selective androgen receptor modulators (Cureus, 2024).
View on PubMedSelective Androgen Receptor Modulators for the Prevention and Treatment of Muscle Wasting
Reviewed SARMs including LGD-4033 class compounds as emerging agents for muscle wasting in cancer and sarcopenia, showing anabolic effects on muscle with selectivity away from prostate and other tissues (Curr Opin Support Palliat Care, 2013).
View on PubMedStudy Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator
Described Phase 3 clinical development of a SARM for cancer-related muscle wasting, demonstrating the evidence base and clinical application model for selective androgen receptor modulators as a drug class (Curr Oncol Rep, 2016).
View on PubMedRelated Peptides
Prefer to message first?
Chat with our team on WhatsApp. We typically reply within minutes.
Chat about LGD-4033